The Naomi Berrie Diabetes Center’s Diabetes Research Panel will be held on Monday, April 30th from 6 pm to 8 pm at the JP Morgan Chase & Co at 270 Park Avenue. If you are interested in hearing from leading scientists working in the field of diabetes research, you will be interested in attending this annual event, which this year is free of charge in commemoration of the Berrie Center’s 20th anniversary.
“Our panelists this year will showcase the rich collaborations between researchers at the Berrie Center and other Columbia departments as well as collaborations outside of Columbia,” said Robin Goland, MD, Co-Director of the Berrie Center and the J. Merrill Eastman Professor of Clinical Diabetes at Columbia. Added Rudolph Leibel, Co-Director of the Berrie Center and the Christopher J. Murphy Professor of Diabetes Research, “We have invited individuals who are experts in research technologies relevant to diabetes, and a CEO of a company that was started using discoveries made at the Berrie Center.”
Our aim will also be to provide an update on the research initiatives that many of the people in the audience will have heard about from our past research panels, tie the work back to how it relates to the Berrie Center’s patients and families and explain the impact private philanthropy can have on pushing research and treatment forward.
The panelists for the event this year will be Drs. Goland and Leibel; Domenico Accili, Russell Berrie Foundation Professor of Diabetes; Dr. Andrea Califano, PhD, Clyde and Helen Wu Professor of Chemical and Systems Biology in the departments of Biochemistry and Molecular Biology; Dr. Rui Costa, PhD, Professor of Neuroscience, Chief Executive Officer Zuckerman Mind Brain Behavior Institute and Charles Queenan, Co-Founder and CEO of Forkhead BioTherapeutics, Inc.
Said Dr. Leibel, “Virtually all of the research in the diabetes center relies on the use of constantly shifting technologies that encompass special imaging and sequencing equipment, more powerful computers and complex analytic strategies. We propose to show the audience some specific examples, and also to highlight some of the ‘alliances’ we have made to expedite our progress.